Heteroarylpyrrolopyridinones active as kinase inhibitors

Details Heteroarylpyrrolopyridinones active as kinase inhibitors Heteroarylpyrrolopyridinones active as kinase inhibitors

2005-12-19

2009-11-17

Andres, Janet L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S113000

Reexamination Certificate

active

07618982

ABSTRACT:
Compounds represented by formula (I)wherein A, R1, R2, R3, R4, R5and R6are as defined in the specification or a pharmaceutically acceptable salt or solvate thereof,compositions thereof, and methods of use thereof.

REFERENCES:
patent: 6417202 (2002-07-01), Kawai et al.
patent: WO 00/69846 (2000-11-01), None
patent: WO 01/98299 (2001-12-01), None
patent: WO 02/12242 (2002-02-01), None
patent: WO 03/014090 (2003-02-01), None
patent: WO 03/027114 (2003-04-01), None
patent: WO 03/028720 (2003-04-01), None
patent: WO 2004/058762 (2004-07-01), None
patent: WO 2005/013986 (2005-02-01), None
patent: WO 2005/014572 (2005-02-01), None
patent: WO 2005/058762 (2005-06-01), None
Lipinski C.A. et al., “2-Amino-and 2-Guanidino-4-Thiazolylpyrimidines”,J. Heterocyclic Chem., 22:1723-1726 (1985).
Cohen P., “The Development and Therapeutic Potential of Protein Kinase Inhibitors”,Current Opinion in Chemical Biology, 3:459-465 (1999).
Montagnoli A. et al., “Drf1, a Novel Regulatory Subunit for Human Cdc7 Kinase”,The EMBO Journal, 21(12):3171-3181 (2002).
Montagnoli A. et al., “Cdc7 Inhibition Reveals a p53-Dependent Replication Checkpoint That Is Defective in Cancer Cells”,Cancer Research, 64:7110-7116 (2004).

Affiliated with

Also associated with

Rating

Heteroarylpyrrolopyridinones active as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroarylpyrrolopyridinones active as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylpyrrolopyridinones active as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4111750